“…Both CV-B4-JVB and the strain CV-B4-E2 (originally isolated from a patient after onset of type 1 diabetes (Yoon et al, 1979)) strains formed productive infection but did not induce cpe. Both virus growth and cytolysis were detected for CV-B5 prototype strain Faulkner and the strains DS (that is highly cytolytic in human pancreatic islets in vitro (Ylipaasto et al, 2012)), MPP (in vivo mouse pancreas adapted strain that induces chronic pancreatic inflammation, dysregulation in glucose metabolism, loss of pancreatic acinar tissue, and mild insulitis in mouse (Al-Hello et al, 2005)) and MCA (in vitro adapted to mouse insulinoma cell line, MIN6 (Al-Hello et al, 2009)), E-9 prototype Hill, laboratory strains Barty and strain DM isolated from a patient at the onset of type 1 diabetes (Vreugdenhil et al, 2000), E-11 prototype Gregory and strain D207 isolated from a stool sample of a patient at the onset of type 1 diabetes (Al-Hello et al, 2008) as well as for E-30 prototype strain Bastianni and strain 14916net87 that is highly lytic in human pancreatic islets in vitro (Roivainen et al, 2002). surface of most of the cells using immunofluorescence technique (Fig 5). The receptor for Coxsackie B viruses (Coxsackie-adenovirus receptor, CAR) was detected in the surface of a subset of cells.…”